Article
Glioblastoma multiforme: insights into pathogenesis, key signaling pathways, and therapeutic strategies
26 Feb 2025
Abstract excerpt
Glioblastoma multiforme (GBM) is the most prevalent and aggressive primary brain tumor in adults, characterized by a poor prognosis and significant resistance to existing treatments. Despite progress in therapeutic strategies, the median overall survival remains approximately 15 months. A hallmark of GBM is its intricate molecular profile, driven by disruptions in multiple signaling pathways, including...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
